Center for drug evaluation and research (cder) office of management (OM) strategic portfolio management consulting
Ended Awarded Last action
- Contract number
- HHSF22315007
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5 Part of Mckinsey & Company, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,647,675
Award facts
- Contract value 100% obligated
- $1,647,674.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20857, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$65,907 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,713,582 |
About this award
This is a federal contract award made by the Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C., a global management consulting firm. The contract, valued at $1,647,674.58, is for strategic portfolio management consulting services to support the Center for Drug Evaluation and Research (CDER) Office of Management (OM).
The contract is a Blanket Purchase Agreement (BPA) call order under the General Services Administration's (GSA) Professional Services Schedule (PSS). It does not have a set-aside designation. McKinsey will provide consulting expertise in areas such as organizational transformation, strategic planning, data analytics, and program implementation support to help the FDA address complex challenges. This award is part of McKinsey's broader federal contracting portfolio, which includes work with the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and NASA on initiatives like COVID-19 response, strategic transformation, and modernization efforts.
Quick answers
Who was awarded contract HHSF22315007?
HHSF22315007 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on August 20, 2015.
How much is contract HHSF22315007 worth?
The government has obligated $1,647,675 on HHSF22315007.
Is contract HHSF22315007 an order under another contract?
Yes. HHSF22315007 is a BPA call under GS10F0118S-HHSF223201010014B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract HHSF22315007 competed?
The extent of competition for HHSF22315007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award